M&T Bank Corp Medpace Holdings, Inc. Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 3,162 shares of MEDP stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,162

Previous 2,867 10.29%

Holding current value

$1.05 Million

Previous $1.16 Million 12.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$372.0 - $424.34 $109,740 - $125,180	295 Added 10.29%	3,162 $1.3 Million
Q1 2024 May 07, 2024	SELL	$284.87 - $413.31 $35,039 - $50,837	-123 Reduced 4.11%	2,867 $1.16 Million
Q4 2023 Feb 06, 2024	BUY	$227.52 - $312.68 $383,371 - $526,865	1,685 Added 129.12%	2,990 $916,000
Q3 2023 Nov 02, 2023	BUY	$233.98 - $281.67 $60,132 - $72,389	257 Added 24.52%	1,305 $315,000
Q2 2023 Aug 09, 2023	SELL	$187.26 - $240.17 $6,741 - $8,646	-36 Reduced 3.32%	1,048 $251,000
Q1 2023 May 11, 2023	BUY	$174.31 - $239.52 $6,275 - $8,622	36 Added 3.44%	1,084 $203,000
Q4 2022 Feb 13, 2023	BUY	$153.06 - $226.57 $7,499 - $11,101	49 New	49 $10,000
Q4 2022 Feb 13, 2023	BUY	$153.06 - $226.57 $152,906 - $226,343	999 Added 2038.78%	1,048 $222,000
Q2 2022 Aug 05, 2022	BUY	$130.2 - $168.03 $294,772 - $380,419	2,264 Added 181.12%	3,514 $525,000
Q1 2022 May 09, 2022	BUY	$138.87 - $214.31 $38,189 - $58,935	275 Added 28.21%	1,250 $204,000
Q4 2021 Feb 07, 2022	SELL	$182.74 - $227.9 $22,842 - $28,487	-125 Reduced 11.36%	975 $212,000
Q3 2021 Oct 28, 2021	BUY	$170.18 - $198.21 $187,198 - $218,031	1,100 New	1,100 $208,000

Others Institutions Holding MEDP

# of Institutions

654

Shares Held

25.6M

Call Options Held

38.7K

Put Options Held

79.5K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account